Update on diagnosis and therapy of plasma cell dyscrasias

Plasma cell Disorder, Diagnosis and Treatment : DR. Anup J DevasiaПодробнее

Updates on Efficacy/Safety Results from MonumenTAL-1 (Talquetamab) in RRMM patientsПодробнее

Myeloma Background, Shared Decision Making, and Smoldering MM UpdateПодробнее

Therapeutic Outcome Differences in Myeloma and Precursor Lesions, by Race (IMPACT Audio Lessons)Подробнее

Diagnosing and treating AL amyloidosis: a 2020 update from Dr Morie GertzПодробнее

Multiple Myeloma UpdateПодробнее

Multiple Myeloma Update: Frontline TherapyПодробнее

Debate: Ideal Treatment fro Smoldering MyelomaПодробнее

Diagnosis and Risk Stratification of Plasma Cell Disorders (pt 1 of 5 - IMF ASH Satellite)Подробнее

Latest updates on treating plasma cell dyscrasiasПодробнее

Myeloma: why PROMISE?Подробнее

MCRT Detroit 2017: Dr. Craig Cole on Understanding Your Type of MyelomaПодробнее

Therapeutic Outcome Differences in Myeloma and Precursor Lesions, by Race (IMPACT Podcast)Подробнее

Know Your Myeloma Therapy: What's Available for Consolidation Therapy?Подробнее

Innovations in the Treatment of Amyloidosis Suzanne Lentzsch M.D., PhDПодробнее

Multiple Myeloma - Nebraska MedicineПодробнее

Complications of multiple myeloma includeПодробнее

Multiple Myeloma, Waldenström macroglobulinemia, MGUS, MGRS - Plasma Cell Dyscrasias - IntroductionПодробнее

Update in Multiple MyelomaПодробнее

Amyloidosis: diagnosis and stem cell transplantationПодробнее